SURGIFOAM ABSORBABLE GELATIN SPONGE, USP

Agent, Absorbable Hemostatic, Collagen Based

FDA Premarket Approval P990004

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the surgifoam absorbable gelatin sponge, u. S. P. This device is indicated for surgical procedures (except urologic, ophthalmic and neurologic) for hemostasis, when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical.

DeviceSURGIFOAM ABSORBABLE GELATIN SPONGE, USP
Classification NameAgent, Absorbable Hemostatic, Collagen Based
Generic NameAgent, Absorbable Hemostatic, Collagen Based
ApplicantFERROSAN MEDICAL DEVICES A/S
Date Received1999-01-22
Decision Date1999-09-30
PMAP990004
SupplementS
Product CodeLMF
Docket Number99M-4776
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewNo
Combination Product No
Applicant Address FERROSAN MEDICAL DEVICES A/S p.o. Box 151 Route 22 West somerville, NJ 08876
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P990004Original Filing
S056 2022-07-01 135 Review Track For 30-day Notice
S055 2022-06-27 135 Review Track For 30-day Notice
S054 2022-03-07 30-day Notice
S053 2021-12-23 30-day Notice
S052 2021-12-20 30-day Notice
S051 2021-11-22 30-day Notice
S050 2021-09-28 30-day Notice
S049 2021-07-26 Special (immediate Track)
S048 2021-05-03 30-day Notice
S047 2021-04-02 30-day Notice
S046
S045
S044
S043 2020-08-26 30-day Notice
S042 2020-07-30 Special (immediate Track)
S041 2020-06-24 30-day Notice
S040 2020-06-08 30-day Notice
S039
S038 2020-03-19 30-day Notice
S037 2020-02-18 30-day Notice
S036 2019-10-01 Special (immediate Track)
S035 2019-02-04 135 Review Track For 30-day Notice
S034
S033 2018-09-05 135 Review Track For 30-day Notice
S032 2017-08-25 30-day Notice
S031 2017-05-04 30-day Notice
S030 2017-02-09 30-day Notice
S029 2016-01-27 30-day Notice
S028 2015-03-06 Normal 180 Day Track No User Fee
S027 2015-02-18 30-day Notice
S026 2015-02-18 30-day Notice
S025 2014-10-24 Normal 180 Day Track
S024 2014-04-22 Normal 180 Day Track No User Fee
S023 2012-10-22 135 Review Track For 30-day Notice
S022 2012-06-18 Special (immediate Track)
S021 2011-02-04 30-day Notice
S020
S019 2010-10-18 Normal 180 Day Track
S018 2010-06-23 Real-time Process
S017 2010-03-02 Real-time Process
S016 2009-07-06 Real-time Process
S015 2008-09-03 30-day Notice
S014 2008-06-27 30-day Notice
S013 2007-07-05 Normal 180 Day Track
S012 2007-06-20 Normal 180 Day Track
S011 2007-03-19 Real-time Process
S010 2006-08-30 Real-time Process
S009 2005-12-20 Real-time Process
S008 2005-03-10 Real-time Process
S007 2004-11-16 Normal 180 Day Track No User Fee
S006 2004-05-10 Real-time Process
S005 2004-01-26 Normal 180 Day Track No User Fee
S004 2002-08-23 Real-time Process
S003 2000-10-02 Real-time Process
S002 1999-11-16 Real-time Process
S001 1999-11-15 Real-time Process

NIH GUDID Devices

Device IDPMASupp
15712123000158 P990004 001
15712123000172 P990004 002
15712123000189 P990004 002
15712123000202 P990004 002
15712123000226 P990004 003
15712123000264 P990004 004
15712123000240 P990004 004
15712123000325 P990004 008
15712123000288 P990004 008
15712123000318 P990004 008
15712123000141 P990004 010

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.